Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine.
about
A lost track in ICHD 3 beta: A comprehensive review on osmophobia.Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.The psychometric properties of the Comprehensive Headache-related Quality of life Questionnaire (CHQQ) translated to Serbian.Design, construction, and technical implementation of a web-based interdisciplinary symptom evaluation (WISE) - a heuristic proposal for orofacial pain and temporomandibular disorders.Perceived stress in patients with migraine: a case-control study.Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents.Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting.Altered pupillary light response scales with disease severity in migrainous photophobia.Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality.Psychological Distress and Drawing Tests among Women with Breast Cancer.Effect of Vitamin D Deficiency on the Frequency of Headaches in Migraine.Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter studyAggression and its association with suicidality in migraine patients: a case-control study
P2860
Q36213539-2A454908-8AE3-4483-A0B9-4E599CE5F051Q36869674-4EA6DCBF-8F1F-4172-A1A4-9D9A7478DCB3Q37201449-ECEF681F-A6E1-4A17-9E05-780748DADEEEQ37222733-6D65E2E8-39EE-4218-B6C1-59432A853ECAQ38400891-986F71EE-0BC4-44A4-BF7F-A6E29F1DB285Q39023201-3E6D56F7-ADDE-48D0-AF65-64785656928EQ39642015-E49310EC-4698-4047-BBD1-DCC49E9C6611Q40459487-3E7E0844-A862-487C-BFCC-0D6D320888D9Q41122998-14557874-76A4-4B55-8360-C4ABA148E71AQ55074453-D2F0C312-7914-43FD-BF8B-DD71860C0187Q55442529-FF267656-490B-4CA2-9382-619EF2EBF44FQ57213095-79F2E1AE-1483-4957-B93B-08786B5E6A25Q58783505-F129E957-D711-40CD-A5DC-D5D838EB24D5
P2860
Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Validation of the Generalized ...... D-2 in patients with migraine.
@ast
Validation of the Generalized ...... D-2 in patients with migraine.
@en
type
label
Validation of the Generalized ...... D-2 in patients with migraine.
@ast
Validation of the Generalized ...... D-2 in patients with migraine.
@en
prefLabel
Validation of the Generalized ...... D-2 in patients with migraine.
@ast
Validation of the Generalized ...... D-2 in patients with migraine.
@en
P2860
P1476
Validation of the Generalized ...... D-2 in patients with migraine.
@en
P2093
Jong-Geun Seo
Sung-Pa Park
P2860
P2888
P356
10.1186/S10194-015-0583-8
P577
2015-11-23T00:00:00Z
P5875
P6179
1043637901